REDWOOD CITY, Calif., April 22 Cardica, Inc.(Nasdaq: CRDC) today announced that it will release financial results for itsfiscal third quarter ended March 31, 2008, on Tuesday, April 29, 2008, afterthe markets close, and the company's management will host a conference call at4:30 p.m. Eastern Time to discuss the financial results and provide an updateon the company's business.
Conference Call Details
To access the live conference call on April 29, 2008, at 4:30 p.m. EasternTime via phone, please dial 866-700-6067 in the United States and Canada or617-213-8834 internationally. The passcode is 73889016. Please dial inapproximately 10 minutes prior to the start of the call. A telephone replaywill be available beginning approximately one hour after the call through May6, 2008, and may be accessed by dialing 888-286-8010 from the United Statesand Canada or 617-801-6888 internationally. The replay passcode is 87854369.
To access the live and subsequently archived webcast of the conferencecall, go to the Investor Relations section of Cardica's website athttp://www.cardica.com. Please connect to the website at least 15 minutesprior to the call to allow for any necessary software downloads.
The webcast is also being distributed through the Thomson StreetEventsNetwork. Individual investors can listen to the call athttp://www.earnings.com, Thomson's individual investor portal, powered byStreetEvents. Institutional investors can access the call via ThomsonStreetEvents (http://www.streetevents.com), a password-protected eventmanagement site.
About Cardica, Inc.
Cardica is a leading provider of automated anastomosis systems forcoronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutureswith easy-to-use automated systems, Cardica's products provide cardiovascularsurgeons with rapid, reliable and consistently reproducible anastomoses, orconnections of blood vessels, often considered the most critical aspect of theCABG procedure. Cardica's C-Port systems are marketed in Europe and the UnitedStates. The PAS-Port(R) Proximal Anastomosis System is marketed in Europe andJapan and is being evaluated currently in a pivotal trial in the United Statesand Europe. Cardica also is developing additional devices with Cook Medical tofacilitate vascular closure and other surgical procedures.
SOURCE Cardica, Inc.